Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01846819 · ClinicalTrials.gov registry record
Factors Associated With End Stage Liver Disease
A clinical trial, sponsored by NYU Langone Health.
- Terminated
- Registry status
- 27
- Enrollment target
NCT01846819 is a clinical trial that was terminated before completion, run by NYU Langone Health. The registered enrollment target is 27 participants.
The verdict
NCT01846819 was terminated before completion, sponsored by NYU Langone Health.
- TERMINATED
- Registry status
- 27 participants
- Enrollment target
Study Summary
100 ambulatory cirrhotic patients attending a liver transplant clinic will undergo a comprehensive clinical evaluation for severity of liver disease, anemia, depression, and fatigue. Fatigue will be assessed with the FIS and sub-maximal exercise capacity with the 6-minute walk test (6MWT), a standardized exercise test that measures the distance that a patient is capable of walking in 6 minutes (6MWD). Depression will be assessed by using three well-known questionnaires. The SF-36, Beck's Depression Inventory (BDI-II), EQ-5D, and the Psychological General Well-Being Index (PGWBI). Univariate analysis will be performed to select the factors that potentially are associated with the scores as indicated by a P value \<.20; the selected factors will then be entered in a stepwise regression to create a multivariate model giving the combination of factors that are significantly associated with the measure of fatigue and depression. Hemoglobin (Hb) levels will then be added to the model in order to test its significance while controlling for the other factors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2012-07 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01846819
The ClinicalTrials.gov registry entry for NCT01846819 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01846819 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01846819 about?
NCT01846819 is a clinical study titled "Factors Associated With End Stage Liver Disease". 100 ambulatory cirrhotic patients attending a liver transplant clinic will undergo a comprehensive clinical evaluation for severity of liver disease, anemia, depression, and fatigue. Fatigue will be assessed with the FIS and sub-maximal exercise capacity with the 6-minute walk test (6MWT), a standar...
What is the current status of trial NCT01846819?
This trial is currently terminated. The enrollment target is 27 participants. The study started on 2012-07. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01846819?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.